Sign Up For Email Updates:

AICR Blog loading...
More from the blog »
WCRF/AICR
Global Network

Abnormal Receptor for a Vitamin A Derivative in Promyelocytic Leukemia (1994)

Title:

Abnormal Receptor for a Vitamin A Derivative in Promyelocytic Leukemia

Key words:

acute promyelocytic leukemia, retinoic acid, vitamin A, abnormal fusion protein

Research Institution:

University of Pittsburgh

Location:

Pennsylvania

Researcher:

Robert Redner

Project Description:

Based on the observation that Acute Promyelocytic Leukemia (APL) can be reversed by treatment with retinoic acid, a natural derivative of vitamin A, Dr. Redner investigated the molecular mechanism underlying the success of this therapy in APL. He sought to determine whether a specific abnormal fusion protein (NPM-RAR) interferes with the function of the normal retinoic acid receptor protein.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Richard Ensminger

Richard K. Ensminger

Director of Planned Giving

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note